<html xmlns="http://www.w3.org/1999/xhtml"><head>
        <meta http-equiv="Content-Type" content="text/html; charset=utf-8">
        <meta name="viewport" content="width=device-width, height=device-height, initial-scale=0.5, minimum-scale=0.5, user-scalable=yes, maximum-scale=2.0, target-densitydpi=device-dpi" />
				<meta name="robots" content="all"/>
        <meta name="description" content="description">
        <meta name="keywords" content="">
        <title>Page 294 - MIMS April 2020 E4</title>
<style type="text/css">
<!--
body {
	margin-left: 0px;
	margin-top: 0px;
	margin-right: 0px;
	margin-bottom: 0px;
}
  
#container {margin:50px auto;padding:0px;width:910px;}
#left-button{ width:90px; height:100%;float:left }
#middle{ width:730px; margin:0px; float: left;}
#right-button{ width:90px; float:left;}
html, body, div, ul, li, dl, dt, dd, h1, h2, h3, h4, h5, h6, form, input, dd,select, button, textarea, iframe, table, th, td { margin: 0; padding: 0; }
img { border: 0 none; displayblock}
span,ul,li,image{ padding:0px; margin:0px; list-style:none;}
#top-title{ width:714px; margin-bottom:10px; float:left; padding:0px 8px}
#top-title2{ width:320px;  float:right;}
#content{ width: 730px; float:left;float:left;word-wrap: break-word;}
#content-top{ width:730px; background-image:url(images/top_bg.jpg); height:56px; background-repeat:no-repeat; float:left;}
#content-top1{ width:70%; padding:16px 0px 0px 30px; font-family:Arial, Helvetica, sans-serif; font-size:24px; color:#636363;float:left;}
#content-top2{ width:60px; float:right; padding:25px 30px 0px 0px;font-family:Arial, Helvetica, sans-serif; font-size:11px; color:#2f2f2f; font-weight:bold; text-align:right}
#content-middle{ width:730px; background-image:url(images/middle_bg.jpg); background-repeat:repeat-y;float:left;}
#content-middle1{ width:475px; padding:25px 0px 25px 35px; font-family:Arial, Helvetica, sans-serif; font-size:12px; color:#636363; line-height:150%;float:left;}
#content-middle2{  padding:7px; float:right; margin:25px 35px 0px 0px; border:solid 1px #c8c8c9; background-color:#FFF; text-align:center}
#content-bottom{ width:730px; background-image:url(images/bottom_bg.jpg); background-repeat:no-repeat; height:58px;float:left;}
#content-bottom2{ width:110px; height:42px; margin:0px auto; padding-top:4px;}
#input{ width:58px; height:20px; background-color:#FFF; border:solid 1px #dfdfe0; color:#636363; text-align:center; font-size:11px;}
.font1{ font-family:Arial, Helvetica, sans-serif; font-size:10px; color:#2f2f2f;}
.font1 a:link{
	text-decoration: none;
    color:#2f2f2f;

}
.font1 a:visited{
	text-decoration: none;
    color:#2f2f2f;
	
}
.font1 a:hover{
	color: #2f2f2f;
	text-decoration: underline;

}



.text-container {
padding: 20px;
color: #333;
margin-top: 24px;
line-height: 22px;
border-top-left-radius: 3px;
border-top-right-radius: 3px;
}

.use-as-video {
float: right;
padding-left: 20px;
}
.cc-float-fix:before, .cc-float-fix:after {
content: "";
line-height: 0;
height: 0;
width: 0;
display: block;
visibility: hidden;
}
.use-as-video-img {
cursor: pointer;
position: relative;
width: 320px;
height: 180px;
}
.use-as-video-title {
font-size: 15px;
font-weight: bold;
color: #000000;
padding-bottom: 5px;
}
-->
</style>
<script type="text/javascript">
<!--
function MM_preloadImages() { //v3.0
  var d=document; if(d.images){ if(!d.MM_p) d.MM_p=new Array();
    var i,j=d.MM_p.length,a=MM_preloadImages.arguments; for(i=0; i<a.length; i++)
    if (a[i].indexOf("#")!=0){ d.MM_p[j]=new Image; d.MM_p[j++].src=a[i];}}
}

function MM_swapImgRestore() { //v3.0
  var i,x,a=document.MM_sr; for(i=0;a&&i<a.length&&(x=a[i])&&x.oSrc;i++) x.src=x.oSrc;
}

function MM_findObj(n, d) { //v4.01
  var p,i,x;  if(!d) d=document; if((p=n.indexOf("?"))>0&&parent.frames.length) {
    d=parent.frames[n.substring(p+1)].document; n=n.substring(0,p);}
  if(!(x=d[n])&&d.all) x=d.all[n]; for (i=0;!x&&i<d.forms.length;i++) x=d.forms[i][n];
  for(i=0;!x&&d.layers&&i<d.layers.length;i++) x=MM_findObj(n,d.layers[i].document);
  if(!x && d.getElementById) x=d.getElementById(n); return x;
}

function MM_swapImage() { //v3.0
  var i,j=0,x,a=MM_swapImage.arguments; document.MM_sr=new Array; for(i=0;i<(a.length-2);i+=3)
   if ((x=MM_findObj(a[i]))!=null){document.MM_sr[j++]=x; if(!x.oSrc) x.oSrc=x.src; x.src=a[i+2];}
}
//-->
</script>
</head>

<body onload="MM_preloadImages('images/next2.png','images/previous2.png')">
<div id="container">
<div id="left-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page293.html"><img src="images/previous_big.png" width="90" height="80" /></a></p>
</div>
<div id="middle">
  <div id="top-title"><span class="font1">Basic HTML Version</span>
    <div id="top-title2">
      <table width="100%" border="0" align="right" cellpadding="0" cellspacing="0">
        <tr>
        	<td width="66%"> </td>
          <td width="35%" style="display:none" align="right"><img src="images/content.png" width="19" height="16" /></td>
          <td width="31%" style="display:none" class="font1"><a href="">Table of Contents</a></td>
          <td width="6%"><img src="images/view.png" width="19" height="16" /></td>
          <td width="28%" class="font1"><a href="../../MIMS April 2020 E4.html#p=294">View Full Version</a></td>
        </tr>
      </table>
    </div>
  </div>
  <div id="content">
     <div id="content-top">
        <div id="content-top1">Page 294 - MIMS April 2020 E4</div>
        <div id="content-top2">P. 294</div>
     </div>
     <div id="content-middle">
     	
     	  <div class="text-container">
    <div class="use-as-video cc-float-fix">
      <a style="text-decoration: none;" href="../../MIMS April 2020 E4.html#p=294"><img src="../thumb/294.jpg" /></a>
    </div>

    <p class="use-as-video-title"></p>
    <pre style="white-space:pre-line"><code>Anti-Microbials - 18.10 / 18.11                                                2020-04 / 257
       relation.to plasma conc., reproduct.toxic.& teratogenicity in animal   of bosentan/ ciclosporin/ midazolam/ nevirapine/amitriptyline/   Dosage: Falciparum malaria: Course of 7 days. Adults: 600 mg
       studies, do not infus.in same line/cannula as other drug infus.incl.  nortriptyline/ phenytoin/rifabutin/oral sulphonylureas/ nateglinide/  8 hrly. Childr: 10 mg/kg bm 8 hrly.
       parenter.nutrit./bld.prods. /electrol. supplementat., correct electrol.  select. COX-2 inhibits. /tacrolimus/ triazolam/warfarin & zidovudine   Noct.cramps: Adults: 300-600 mg at night. Discont. aft. sev.
       disturbs. bef. admin., mild to mod.hepat.cirrhos., monit. hepat. imp.  incr., theophyll.clear.decr., card.arrhythm.with cisapride/ astemizole,   cramp free nights.
       pts., discont.if S&S consist.with liv.dis. develop., adeq.contracept.in   syncope poss.with concom. amitriptyline, hydrochlorothiaz.incr.plas-  Contraindications: Tinnit., optic.neurit., haemolysis., myasth.grav.
       child-bear.women, other azole hypersens., monit.concom.HIV pro-  ma conc., rifampicin reduc.plasma conc., nevirapine expos. incr., effic.  Side effects: Cinchonism, vis.disturbs., fev., skin rash., dyspn., angi-
       tease inhibit.& non-nucleoside reverse inhibit.for drug toxic./loss of   of oral contracept.poss.affect.  oed., asthma precipitat., thrombocytopen. purpura, haemoglobinur.,
       effic.transcriptase, freq.monit.for toxic. relat.to methadone incl.QT   hypoprothrombinaem., agranulocytos.
       prolong., consid. alfentanil dos.reduct./other opiat.simil.in struct.&   Warnings and special precautions: Discont. immed,if haemolys.
       metabol. by CYP3A4, consid.oxycodone dos. reduct. /other long-act.  appears, avoid in myasth.grav., incr. seiz.& ECG abnorm.with meflo-
       opiat.metabol. by CYP3A4, freq. monit.pts.for resp.depress& other  18.11   Anti-protozoal agents  quin predispos. pt.to dysrhythm., admin.mefloquine at least 12 hrs. aft.
       fentanyl-assoc. adverse events with concom.fentanyl & reduc. fenta-  GARSUN (MDR Listing)  last quinine dose, monit.for QT prolongat.& poss. dysrhythm.in hosp.
       nyl dos.if warrant., poss.revers.vis. disturbs. incl.blurr./alter./enhanc.  if quinine must be giv.in mefloquine-resist. malar., atrial fibrillat., ser.
       vis.percept., monit. prothromb.time with oral anticoags, gluc. monit.   ADCO-METRONIDAZOLE, (Adco Generics)    heart dis., G6PD-defic., hypoglycaem.poss.induc.by antimalar.ther.&
       with sulphonylur., concom.OC’s, monit.for drug toxic./lack of effic.  AI Pharm Ltd [P/S]  is a freq.complic.in F.malaria,
       with HIV protease inhibits./ NNRTI’s.  Metronidazole.
       Drug interactions: Activ.of cytochrome P450 isoenzymes inhibit.  Indications: Urogenit.trichomon., amoebias., giardias, ulcerat.gingi-  BEMETRAZOLE, Ranbaxy [P/S]
       incr.plasma lev.of subst. metabol.by these isoenzymes, rifampicin/   vit., anaerob.bact.infects., post-surg.infect.prophylax.  Metronidazole.
       carbamazepine & phenobarbit.decr.plasma conc., plasma conc.of   (S4) TABS. R/20.2.6/187, 188.  Indications: Urogenit.trichomon., amoebias., ulcerat.gingivit., gi-
       cyclosporin & tacrolimus incr. assoc.with nephrotox., prothrombin   742872-009: 200 mg, 250, R50,62  ardias., anaerob.infects.
       time incr.with concom.oral anticoags., plasma lev.of sulphonylurea   701076-003: 400 mg, 100, R51,20  (S4) TABS. 29/20.2.6/0745, X/20.2.6/84.
       incr., plasma lev.of statins incr. assoc.with rhabdomyolys., incr.sedat.  Dosage: Urogen. trichomon: Treat male & fem. Adults: 2 g as   821705-016: 200 mg, 500, R80,18
       eff.of benzodiazepines metabol.by CYP3A4, incr.plasma lev.of vinca   sngl.dose or 200 mg 3xdly x7 days/ 400 mg 2xdly.x5 days. Childr:   788708-023: 400 mg, 500, R107,71
       alkaloids lead.to neurotoxic., steady state Cmax & AUC decr.by efa-  7-10 yrs: 100 mg 3xdly. 3-7 yrs: 100 mg 2xdly. 1-3 yrs: 50 mg   Dosage: Urogenit.Trichomon: 400 mg 2xdly x7 days.or 2 g as
       virenz & evavirenz steady state Cmax & AUC incr., concom.ritonavir   3xdly x7 days.  sing.dos. x1 day.
       decr. Cmax & AUC,  two way interaction betw.voriconazaole & phe-  Amoebias: Suscept.adults: 800 mg 3xdly x5-10 days or 5x400 mg   Amoebias: 800 mg 3xdly. x5 days or 2 g once dly. x3 days.
       nytoin/voriconazole & rifabutin & voriconazole & omeprazole, incr.  tabs as sngl.dos.x3 days. Childr. 7-10 yrs: 400 mg 3xdly. 3-7 yrs:   Ulcerat.gingivit: 400 mg 2xdly. x3 days.
       plasma conc.of methadone, clinic.signif.interacts.with cyclospor./   200 mg 4xdly. 1-3 yrs: 200 mg 3xdly x5-10 days. Less suscept.  Giardias: 2 g 1xdly. x3 days.
       tacrolimus, incr.Cmax  & AUCt of prednisolone, metabol.poss.inhib.  pts. & in chron.amoeb.hepatit: Adults: 400 mg 3xdly. x5-10 days   Anaerob.infects: Adults: 400 mg 3xdly. x7 days. Childr.& infts:
       with HIV protease inhibits., Cmax,  AUC0–∞  and elimin.half-life of   or 2 g dly.as sngl.dos.x2 days. Childr: 7-10 yrs: 200 mg 3xdly. 3-7   7 mg/kg bm 3xdly.
       oxycodone incr., Cmax & AUC of concom.ibuprofen/diclofenac incr.  yrs: 100 mg 4xdly. 1-3 yrs: 100 mg 3xdly x5-10 days. Amoeb.liv.  Prevent.anaerob.infects: 400 mg 6 hrly.x2-3 days pre-op.
                                                                  Contraindications: Bld.dyscras., act.CNS dis., safety in pregn.&
                                     abscess & other forms of extra-intestin.amoebiases: Adults:
       ZUCAN, Pharma Dynamics [P/S]  500-800 mg 3xdly. X5-10 days or 2 g dly.as sngl.dos. x2 days. Chil-  lactat.not est.
       Fluconazole.                  dr: 7-10 yrs: 200 mg 3xdly. 3-7 yrs: 100 mg 4xdly. 1-3 yrs: 100 mg   Side effects: Metall.taste, furr.tong., N&V, GI effs., drowsin., head-
       Indications: Adults & childr:: Cryptococ. meningit. in ment.alert   3xdly x5-10 days. Sympt.less pts. who have pass.cysts: Adults:   ache, pseudomembr.colit., prolong.treatm: periph.neuropathy, CNS
       pts.without local. neurologic. signs & follow-up ther.aft. amphotericin   400-800 mg 3xdly.x5-10 days. Childr: 7-10 yrs: 200-400 mg 3xdly.   effs., temp.mod.leukopen., skin rash, prurit., anaphylax., urethr.dis-
       B ther., maint.ther.to prev.cryptococ. dis.relapse in AIDS pts., system.  3-7 yrs: 100-200 mg 4xdly. 1-3 yrs: 100-200 mg 3xdly x5-10 days.  comf., dark urine.
       candidias., oropharyng. & oesophag.candidias., fung.infect. prophy-  Giardias: Adults: 2 g/day x3 days. Childr: 7-10 yrs: 1 g/day.   Special precautions: Avoid alcoh., discont.at signs of periph.neu-
       lax. in pts. receiv.chemo and/or radiother.  3-7 yrs: 600-800 mg/day. 1-3 yrs: 500 mg/day x3 days. Rep.aft.2   ropathy/CNS toxic., sev.liv.dis.
       (S4) INFUS, A45/20.2.2/0543. 2 mg/ml.  wks.if necess.      Drug interactions: Effect of warfar.enhanc.
       721599-001: 2 mg/ml, 100 ml, R50,35  Ulcerat.gingivit: Adults: 200 mg 3xdly.x3 days or 400 mg 2xdly.
       721600-001: 2 mg/ml, 200 ml, R100,69  x3 days. Childr: 7-10 yrs: 100 mg 3xdly. 3-7 yrs: 100 mg 2xdly. 1-3   BIO-METRONIDAZOLE, Biotech [P/S]
       Dosage: Cont.ther.requir.multipl.dos.treatm.until lab. tests & clinic.  yrs: 50 mg 3xdly x3 days.  Metronidazole.
       paramet.indic.act.infect.subsid. Maint.ther.usually reqd.in AIDS pts.  Anaerob.infects: Treatm: Adults: 400 mg 3xdly x7 days. Childr.&   Indications: Urogenit.trichomon., amoebias., ulcerat.gingivit., giar-
       with cryptococc. meningit/recurr.oropharyng.candidias. Infts. und.2   infts: 7,5 mg/kg bm 3xdly x7 days.  dias., anaerob.bact.infects., post-op anaeroab.bact.infect.prophylax.
       wks.to receiv.childr.dos.but only given once every 72 hrs. Infts.2-4   Prevent: Adults: 2 g sngl.dose pre-op.& 200 mg 3xdly x7 days post-op.  (S4) TABS, V/20.2.6/0371
       wks.to receiv.childr. dos. every 48 hrs. Max.adult dly.dos.of 400 mg   Contraindications: Bld.dyscras., act.CNS dis., pregn., lactat.  707242-004: 400 mg, 500, R117,62
       not to be exceed.in childr.   Side effects: GI disturbs., coat.tong., dry mouth, headache, skin rash,   Dosage: Trichomon: 200 mg 3xdly.x7 days.4-6 wk interv.betw.
       Infus.may be infus.at max.rate of 200 mg/hr.with compat. admin.  vertigo, depress., insomn., drowsin.,urethr.discomf., urine darken.  courses if rep.course necess. when male partn.also to be treat.
       fluid. Mix.with any other drugs not recomm.  Drug interactions: Disulfiram-like react.with alcoh., anticoag.eff.  OR 2 g as sngl. dos.
       Cryptococ.meningit: Adults: 400 mg on 1st day, then 200-400 mg   of warfarin enhanc.  Amoebias: 800 mg 3xdly. x5-10 days. Childr: 35-50 mg/kg as dly
       dly depend.on clinic.respon. Duration usually 6-8 wks.  Warnings: Pseudomembr.colit.  dos.in 3 div.dos.x10 days.
       Childr.: 6–12 mg/kg/ day depend.on severit.                Giardias: Same dos.as for trichomon.OR 2 g dly. x3 success.days.
       Maint.ther.to prevent.cryptococ.meningit. relapse in AIDS   ADCO-METRONIDAZOLE IV INFUS, (AI Crit Care) AI Ltd [P/S]  Childr: Same dos.as amoebiasis.
       pts: Adults: 100-200 mg dly. aft.full course of prim.ther.completed  Metronidazole.  Anaerob.infects: Adults: 400 mg 3xdly. x7 days alone/in conjunct.
       System.candidias: Adults: Init. 400 mg on 1  day, then 200 mg   Indications: Emerg.pre-op load.when oral/rect. admin. not poss.  with antibact.agents. Childr: 7 mg/kg bm 3xdly.
                           st
       dly. Dos.may be incr.to 400 mg dly.depend.on clinic. respons. Childr.:   in anaerob.bact.infects., symptomat. amoebias., giardias., post-op   Prevent.anaerob.infects: 1-2 g as sngl.dos.on admiss.then 200 mg
       6–12 mg/kg / day depend.on severit.  prophylax. of anaerob.infects.in gynae./ appendicect. & colon surg.,   3xdly.bef.op & x7days thereaft.
       Oropharyngeal candidias: Adults: 50-100 mg once dly.x7-14   pelv.abscess & post op wound infects.from which one or more an-  (S4) IV INJ, 42/20.2/0567
       days/long.in sev.immunocompris. pts. To prev.relapse in AIDS pts.  aerob. have been isolat.  Indications: Anaerob.infects.in post-op wound infects. & pelv.in-
       admin.150 mg once wkly.aft.full course of prim.ther.completed Childr:   (S4) IV INFUS, 27/20.2.6/0562. 500 mg/100 ml  flamm.dis.,  post-op prophylax. of anaerob. infects. admin.bef./aft.
       Init.6 mg/kg on 1  day follow.by 3 mg/kg once dly. x2 wks.at least to   708770-001: 1x100 ml viaflex, R17,43.  appendicect./ gynae. & colon surg. when oral route unsuit.
              st
       low. likelihood of relapse.   708770-002: 50x100 ml viaflex, R872,45.  718918-001: 500 mg/100 ml, 1X100 ml, R14,03
       Oesophag.candidiasis: Adults: Init.200 mg on 1  day follow.   Dosage: Do not add.other meds.as incompatibil. poss. Substit.oral   Dosage: Treatm: Adults & childr.over 12 yrs: 100 ml (500 mg) IV
                              st
       by 100-200 mg dly.with dos.of upto 400 mg dly if no clinic.respons.   med.as soon as feasible.  8 hrly.infus.at rate of 5 ml/min. May be admin.alone or concurr.(but
       Treat for min.3 wks. & x2 wks.aft.sympt.resolv. Childr.: Init. 6 mg/  Treatm: Adults & childr.over 12 yrs: Recomm.IV dos: Load.dos:   separat.) with other appropr.antibiot.agents. Childr.und. 12 yrs: As
                                     15 mg/kg follow.6 hrs.later by maint. dos.of 7,5 mg/kg 6 hrly x7-10
       kg on 1  day follow.by 3 mg/kg once dly. with dos.of upto 12 mg/  for adults but sngl.IV dos. bas.on 1,5 ml (7,5 mg)/kg bm & oral dos.
          st
       kg/day accord.to pt. condit.& respons. Treat for min.3 wks. & x2   days. When 100 ml infus.giv.8 hrly.inj.rate should be 5 ml/min. Childr.  of 7,5 mg/kg bm.
       wks. aft.sympt.resolut.       und. 12 yrs: As for adults but sngl.IV dos. bas.on (1,5 ml)7,5 mg/kg bm  Prophylax: Adults & childr.over 12 yrs: 100 ml (500 mg) by IV in-
       Fung.infect.prophylax.in pts.receiv.cytotox. chemo-/radiat.  Prevent: Adults & childr.over 12 yrs: Infus. 100 ml IV immed.  fus.immed.bef./dur.or aft.surg.foll.by same dos.8 hrly unt.oral meds.
       ther: Adults: 50-400 mg dly.bas. on risk profile. Commenc.ther.sev.  bef./dur.or aft.op follow.by same dos. 8 hrly till oral medicat.poss.  can be giv. Childr.und.12 yrs: As for adults but sngl. IV dos.bas.on
       days bef. anticipat. neutropen & contin.x7 days aft. neutrophil count   to compl.7 day course. Childr.und.12 yrs: As for adults but sngl. IV   1,5 ml (7,5 mg)/kg bm & oral dos.of 7,5 mg/kg bm.
       rises above 1000 cells per mm . Childr.: 3–12 mg/kg/day depend.  dos.bas.on (1,5 ml)7,5 mg/kg bm  Contraindications: Bld.dyscras., CNS dis., pregn. & lactat.
                    3
                                     Contraindications: Bld.dyscras., act.CNS dis., pregn. & lactat.
       on extent & durat. of neutropen.                           Side-effects: CNS effs., dizzin., headache, light-headedn., periph.
       Contraindications: Concom.cisapride, pregn. & lactat., multiple   Side effects: GI disturbs.incl.taste disords., headache, dry mouth/  neuropathy/ seiz./leucopen. esp.with prolong ther., atax., unsteadin.,
                                     vag., furred tong., glossit., stomatit., periph.neuropathy esp.at high
       dos.ther.in ren.impairm., avoid concom.astemizole.         encephalopathy, weakn., psych.disords., drowsin., taste chang.incl.
       Side effects: Ser.hepatotox.with fatalit., hepat. fail., hepatit., hepa-  dos./ prolong. use, weakn., dizzin., atax., drowsin., insomn., mood/  metall., dry mouth, thrombophlebit., loc.reacts., hypersens.reacts.
                                     ment.state chang., temp.mod. leucopen., rais.liv.enzymes, skin rash,
       tocell.nocros., jaund., prurit., rashes, urticar., angioed., dry skin, ab-  incl.angioed./anaphylax., skin reacts.incl. erythem. erupt., prurit.,
       norm.odour, alopec., exfoliat.cutan.reacts., hypersens.reacts. incl.  prurit., urticar., cystit., anaphylax., urethr.discomf., dark. urine, throm-  fleet.joint pains resembl. ser.sickn., sore throat/fev., bld.dyscras.,
                                     bophlebit., slight trans.BP falls.
       anaphylax., bld.dyscras., hypercholesterolaem., hypertriglyceridaem.,   pancreatit., urin.tract effs., vag.candidias., GI disturbs., dry mouth,
       hypokalaem., decr.appet., QT prolongat., torsades de pointes, CNS   Special precautions: Monit.treatm.if admin. more than 10 days   furr. tong., stomatit., arthralg., myalg., vis.disords., rais.liv.enzym.,
                                     for signs of periph.neuropathy, discont. it neurologic.S/E noted, sev.
       effs.incl.seiz., fatig., rigors, GI disturbs., taste pervers., thirst, polyruia,   obstruct. hepat. dis., alcoh.cirrhos., sev.ren.dysfunct., avoid alcoh.   cholestat.hepatit., trans.BP falls.
       fem.sex. dysfunct., intermenst. bleed., menorrhag., leukorrh., abnorm.   dur.ther., poss.dos.adjustm.of any antihypertens. med./oral anti-  Special precautions: Monit.treatm.if admin. long. than 10 days, dis-
       vis., hyperton., myalg., inj.site reacts., malaise.  coag., avoid prolong treatm. as carcinogen.in anim.& mutagen.in   cont.if periph.neuropathy S&S /CNS toxic.devel., sev.hepat.impairm.,
       Warnings and special precautions: Monit. liv. funct. periodic.  bact. indic.in stud.  bld.dyscras., act./chron.centr./periph.nerv.syst. dis., concom.alcoh.&
       in pts.receiv.contin.treatm. &gt; 1 mnth. /if pt. develops signs/sympts.  Drug interactions: Poss.disulfiram-like react.with alcoh., eff.of war-  disulfiram poss.incr.S/E, immunolog.respons.in untreat.early syphil.
       suggest.liv. dysfunct., discont.ther.if abnorm.enzyme values persist/  far.enhanc., phenobarb.metabol. at much great.rate.  poss.mask., pseudomembr.colit.report., reduc. concom.antihypertens.
       worsen/ are accomp.by sympts.of hepatotox., AIDS pts.more sus-  dos., monit.leucocyt.count if rep.courses reqd.
       cept.to cutan. reacts., discont.ther,if bull.les./eryth.multiforme devel.,   ASPEN QUININE, (Aspen Pharmacare: Pharma)    Drug interactions: Warfar.eff.enhanc.
       monit.theophyll.conc., concom nevirapine, congenit.malformat.with   Pharmacare [P/S]
       admin.dur.pregn., excret. in breast milk, imp.ren.funct., fluid admin.in   Quinine sulph.  COARTEM, (Sandoz) Novartis [P/S]
       pts req.Na/fluid restrict., hepat./ren.& haematolog. funct. abnormalit.  Indications: Resist.strains of P falciparum malaria, musc.relax.  Artemether 20 mg, lumefantrine 120 mg.
       partic.in pts.with ser.underly. dis. such as AIDS and malign., pts.with   in congenit.myoton.& myoton. contract., nocturn.cramps, myasth.  Indications: Uncomplic.P.falciparum malaria incl. chloroquin. resist.&
       prodysrhythm. condits.        grav.diagnos. test           ac.P.vivax malaria in pts up to 65 kg bm.liv.in endem.& non-endem.
       Drug interactions: Incr.plasma conc.of meds. metabol. by cyto-  (S4) TABS. H967.  areas, appropriat. treatm. to eradicat.liver forms of P.vivax.should be
       chrome P-450 system, warfar. anticoag. effs.incr., plasma conc.  758884-028: 300 mg, 100, R413,39  added for P.vivax or mixed malaria</code></pre>
     	</div>
    
     </div>
     <div id="content-bottom">
       <div id="content-bottom2">
         <table width="110" border="0" cellspacing="0" cellpadding="0">
           <tr>
             <td width="22%" height="44"><a href="page293.html"><img src="images/previous.png" width="26" height="19" id="Image2" onmouseover="MM_swapImage('Image2','','images/previous2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
             <td width="43%">
             	&nbsp;&nbsp;&nbsp;<a href="page289.html">289</a>&nbsp;&nbsp;&nbsp;<a href="page290.html">290</a>&nbsp;&nbsp;&nbsp;<a href="page291.html">291</a>&nbsp;&nbsp;&nbsp;<a href="page292.html">292</a>&nbsp;&nbsp;&nbsp;<a href="page293.html">293</a>&nbsp;&nbsp;&nbsp;<a href="page294.html">294</a>&nbsp;&nbsp;&nbsp;<a href="page295.html">295</a>&nbsp;&nbsp;&nbsp;<a href="page296.html">296</a>&nbsp;&nbsp;&nbsp;<a href="page297.html">297</a>&nbsp;&nbsp;&nbsp;<a href="page298.html">298</a>&nbsp;&nbsp;&nbsp;<a href="page299.html">299</a>
             </td>
             <td width="35%"><a href="page295.html"><img src="images/next.png" width="26" height="19" id="Image1" onmouseover="MM_swapImage('Image1','','images/next2.png',1)" onmouseout="MM_swapImgRestore()" /></a></td>
           </tr>
         </table>
       </div>
     </div>
  </div>
</div>
<div id="right-button">
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p>&nbsp;</p>
  <p><a href="page295.html"><img src="images/next_big.png" width="90" height="80" /></a></p>
</div>


</div>

</body>
</html>
